Senior Director, Scientific Affairs
Celerion
Sabina Paglialunga, PhD is a Senior Director of Scientific Affairs at Celerion. In this key leadership position, she provides scientific, operational and regulatory support for early clinical studies. Sabina serves as an internal subject matter expert for metabolic disease drug development and supports a number of Celerion’s clinical pharmacology strategic initiative. She joined Celerion in 2015 and held several roles with increasing responsibility. Sabina received her PhD in Biochemistry from McGill University, Canada and her training includes three international Postdoctoral Fellowships.